BioBridgeXAll companies

GeneVentiv Therapeutics, Inc.

Biotechnology company · Raleigh, North Carolina, United States

GeneVentiv Therapeutics, Inc. is a biotechnology company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2.5 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1.4 million sold in a notice filed in 2022.

www.geneventiv.comProfile compiled from public records. Is this your company? Request a correction or update

GeneVentiv Therapeutics at a glance

Typebiotechnology company
HeadquartersRaleigh, North Carolina, United States
Earliest incorporation on record2020
Employees (self-reported, 2024)1
SEC CIK1942327

What does GeneVentiv Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $2.5 million in total (2024). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.4 million sold (2022).

Frequently asked questions about GeneVentiv Therapeutics

Where is GeneVentiv Therapeutics headquartered?

GeneVentiv Therapeutics, Inc. is headquartered in Raleigh, North Carolina, United States.

What does GeneVentiv Therapeutics do?

GeneVentiv Therapeutics, Inc. is a biotechnology company.

When was GeneVentiv Therapeutics founded?

The earliest incorporation on record for GeneVentiv Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences